share_log

UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%), etc.

烏龍製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%)等

美股SEC公告 ·  2024/11/18 19:19
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息